Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net loss	$ (6,394,295)	$ (28,563,283)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and depreciation	1,361,628	2,192,982
Common stock and stock option based compensation for employees and board of directors	2,175,072	4,974,519
Accrued non cash performance bonus fair value adjustment	(551,239)
Acquisition contingent consideration fair value adjustment	(4,272,080)	(696,722)
Impairment of intangible assets	2,942,369	15,351,842
Gain on divestiture of subsidiary	1,000,000
Reserve on note received in connection with divestiture of subsidiary	(1,000,000)
Issuance of common stock to vendors	100,372	5,238
Adjustment to operating lease right-of-use assets and liabilities	(110,866)	(8,330)
Changes in operating assets and liabilities:
Accounts receivable	730,738	132,193
Deferred costs/contract assets	(12,229)	433,557
Prepaid expenses and other current assets	(216,018)	(182,410)
Other assets	(948)	149,963
Accounts payable	(274,109)	(419,716)
Accrued liabilities	(294,637)	(120,181)
Deferred revenue/contract liabilities	(393,605)	(2,412,066)
Net cash used in operating activities	(5,209,847)	(9,162,414)
Cash flow from investing activities:
Purchases of equipment	(31,548)	(146,333)
Acquisitions, net of cash acquired		(2,627,261)
Payment of contingent consideration for acquisitions	(1,497,894)	(1,000,000)
Sale of investments		239,314
Net cash used in investing activities	(1,529,442)	(3,534,280)
Cash flows provided by financing activities:
Proceeds from securities purchase agreement, net	2,968,501
Proceeds from exercise of stock options		66,111
Cash provided by financing activities	2,968,501	66,111
Net change in cash, cash equivalents and restricted cash	(3,770,788)	(12,630,583)
Cash, cash equivalents and restricted cash, beginning of year	5,619,083	18,249,666
Cash and cash equivalents, end of year	1,848,295	5,619,083
Non-cash Investing and Financing activities:
Issuance of common stock for satisfaction of contingent liability	974,646	3,059,363
Issuance of common stock for non cash performance bonus	490,357
Lease liabilities arising from right-of-use assets		429,329
Common stock issued for acquisition		2,846,144
Contingent acquisition consideration liability recorded at closing		7,325,000
Common stock issued for purchase of intangible asset - technology		326,435
Issuance of common stock for satisfaction of prior year acquisition liability		734,037
Issuance of common stock for satisfaction of contingent liability, net of note extinguishment		318,571
Extinguishment of note receivable for satisfaction of contingent liability		$ 250,000